Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities Announcement Summary Entity name LTR PHARMA LIMITED Date of this announcement Friday November 06, 2026 The +securities the subject of this notification are: +Other securities issued under an +employee...
Notification regarding unquoted securities - LTP
Filed with ASX · · 6 pages · English
Summary by 6ix AI
LTR Pharma Limited has issued unquoted equity securities under an employee incentive scheme, as detailed in this notification. The total number of securities issued is specified, and they are not intended to be quoted on the ASX. The announcement confirms that these securities will rank equally with existing issued securities in that class. The notification also states that the issuance did not require security holder approval under certain listing rules.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Earlier from LTR Pharma
- Nick Bell Joins LTR Pharma as Strategic Adviser
- Quarterly Activities/Appendix 4C Cash Flow Report
- Results of Meeting
- AGM Presentation
- SPONTAN to be Evaluated in Pulmonary Arterial Hypertension
Later from LTR Pharma
- Change of Director's Interest Notice - M McGuire
- Change of Director's Interest Notice - J Chick
- Change of Director's Interest Notice - L Rodne
- Application for quotation of securities - LTP
Follow LTR Pharma into a list and get an email when it puts out news.
Follow LTR Pharma